Pharma Stories, Blogs, Interviews & Press Releases
NEC, JFCR & Taiho to Develop Shared-Neoantigen Cancer Vaccines
NEC, together with the Japan Cancer Research Institute (JFCR) and Taiho Pharmaceutical, publicized a partnership to crea...
Read Full StoryFDA Approves Otsuka’s Voyxact for IgA Nephropathy (IgAN)
Otsuka's monoclonal antibody Voyxact has received FDA approval for the treatment of primary IgA nephropathy (IgAN) i...
Read Full StoryFDA Approves Durvalumab (Imfinzi) + FLOT Regimen for Resectable Gastric & GEJ Cancer
The U.S. FDA has given the green light to AstraZeneca’s durvalumab (Imfinzi) in combination with the FLOT chemothe...
Read Full StoryFDA Approves Novartis Gene Therapy Itvisma for Spinal Muscular Atrophy (SMA)
The U.S. FDA has granted Novartis' gene therapy Itvisma approval for the treatment of spinal muscular atrophy (SMA)...
Read Full StoryEMA CHMP Recommends 10 New Medicines for Approval
During its meeting from November 10 to 13 in the year 2025, the EMA-CHMP gave out a positive opinion which proposed the...
Read Full StoryBeta Drugs raises Rs 117 cr from HealthQuad and others
Beta Drugs a vertically integrated oncology-focused formulations company, has raised primary capital worth Rs 117 crore...
Read Full StoryRivpra Formulations enters D2C market with a premium skincare brand, Oteria
Rivpra Formulation, an integrated pharmaceutical company, today announced its entry into the D2C segment with the launch...
Read Full StoryPiramal Alternatives invests Rs. 110 cr in Biodeal Pharmaceuticals
As contract manufacturing becomes the new growth driver of the pharmaceutical industry, Piramal Alternatives, the fund m...
Read Full Story